Mercury Biomed Awarded $1.5M National Institutes of Health Grant | AP News
Mercury Biomed received a $1.5 million Phase II STTR grant from NIGMS to advance WarmSmart, a device for peri-operative patient warming. This funding supports clinical trials at Cleveland Clinic, aiming for FDA clearance. WarmSmart offers a novel, non-invasive approach to maintain normothermia, addressing a $2.5 billion market.
Reference News
Mercury Biomed Awarded $1.5M National Institutes of Health Grant | AP News
Mercury Biomed received a $1.5 million Phase II STTR grant from NIGMS to advance WarmSmart, a device for peri-operative patient warming. This funding supports clinical trials at Cleveland Clinic, aiming for FDA clearance. WarmSmart offers a novel, non-invasive approach to maintain normothermia, addressing a $2.5 billion market.